Among second-generation antipsychotics, clozapine is uniquely effective for treatment-resistant schizophrenia. Which receptor binding profile best explains its superior efficacy while also accounting for its seizure-risk side effect?

• A High-affinity D2 blockade with concurrent 5-HT2A blockade and low seizure threshold lowering
• B Selective D4 blockade plus GABA-A agonism that explains seizure risk
• C Partial D2 agonism and full 5-HT1A agonism with NMDA potentiation
• D Loose (low-affinity, fast-dissociating) D2 blockade combined with potent M1 muscarinic antagonism that lowers seizure threshold at high doses ✓

Explanation

Clozapine has relatively low D2 affinity with fast dissociation ('loose binding'), which avoids extra-pyramidal side effects; it acts across multiple receptors including D1-4, 5-HT2, H1, M1-4, and alpha-1/2. Its potent M1 anticholinergic action and GABA-A antagonism (particularly through norclozapine) lower the seizure threshold dose-dependently, making epileptic seizures an important dose-limiting adverse effect. The multi-receptor profile including 5-HT2 and D1 engagement is thought to underlie its superior antipsychotic efficacy.

Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.